{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:30:20Z","timestamp":1762101020425},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2046,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/ki.2010.23","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T15:47:08Z","timestamp":1270655228000},"page":"897-903","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and safety of SBR759, a new iron-based phosphate binder"],"prefix":"10.1016","volume":"77","author":[{"given":"Geoffrey A.","family":"Block","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie L.","family":"Brillhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha S.","family":"Persky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.23_bb0010","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2010.23_bb0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2010.23_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","article-title":"Serum phosphorus levels associate with coronary atherosclerosis in young adults","volume":"20","author":"Foley","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.23_bb0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.23_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome. Possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.23_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0272-6386(88)80119-7","article-title":"Toxic effects of aluminum in end-stage renal disease: discussion of a case","volume":"12","author":"Coburn","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.23_bb0040","first-page":"35","article-title":"Alternative phosphate binders in dialysis patients: calcium carbonate","volume":"6","author":"Slatopolsky","year":"1986","journal-title":"Semin Nephrol"},{"key":"10.1038\/ki.2010.23_bb0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.23_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.23_bb0055","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.23_bb0060","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2215\/CJN.02190507","article-title":"Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease","volume":"2","author":"Sigrist","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.23_bb0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.23_bb0070","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.23_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.23_bb0080","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1523-1755.1999.07311.x","article-title":"Phosphate binders on iron basis: a new perspective?","volume":"73","author":"Hergesell","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2010.23_bb0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ndt\/14.4.863","article-title":"Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients","volume":"14","author":"Hergesell","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.23_bb0090","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.23_bb0095","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"Group KDIGOKC-MW","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.23_bb0100","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2215\/CJN.01660309","article-title":"Phosphate levels and cardiovascular disease in the general population","volume":"4","author":"Foley","year":"2009","journal-title":"In Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.23_bb0105","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2215\/CJN.04741107","article-title":"Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a Multicenter Study","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.23_bb0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/ndt\/5.9.781","article-title":"Iron overload and bone disease in chronic dialysis patients","volume":"5","author":"Van de Vyver","year":"1990","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815541410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815541410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T02:13:44Z","timestamp":1559009624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815541410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0085253815541410"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.23","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}